sible for linking Ca*+ release from internal stores to the activation of voltage-independent Ca*+ current in pancreatic acinar cells. Because muscarinic activation of NlE-115 cells dramatically elevates the intracellular cGMP concentration, we considered the possibility that cGMP might activate Ca*+ current in this excitable cell line as well. This was explored using nystatin perforated-patch voltage clamp and Fura-imaging.
We found that 8-bromo-cGMP, a membrane permeable analog of cGMP, activates a voltage-independent Ca*+ current with properties similar to the current activated by muscarinic agonists. Inhibitors of cGMP formation or the binding of cGMP to its effecters prevents activation of the current by agonist without affecting intracellular Ca*+ release or the content of calcium stores. We conclude that cGMP is the factor necessary for coupling muscarinic receptor occupancy to the activation of Ca*+ current. It is apparent that the IP,-signaling pathway and the cGMP pathway interact at the level of intracellular Ca*+ concentration. This interaction represents a positive-feedback loop linking increases in intracellular calcium ([Cal,) to increased production of cGMP and increased Ca*+ influx. Positive feedback helps to explain the rapid increase in cGMP production (and by inference, NO production) that occurs during muscarinic receptor activation.
MATERIALS AND METHODS
Cell culture. The NlE-115 neuroblastoma cell line, derived from mouse sympathetic ganglion neurons (Amano et al., 1972) , was obtained from the University of California San Francisco Cell Culture Facility and used in passages 3:8. Cells were grown in DMEM with 10% fetal bokine serum (HvClone. Logan. UT) at 37°C in a 10% CO, atmosohere. elated on glass coderslips; and grown to -80% confluence before diffe;entiation kith dimethyl sulfoxide (DMSO) for 5-21 d (Kimhi et al., 1976) . Plated cells were fed every 2-3 d and used 1-2 d after feeding.
Solutions and chemicals. Experiments were carried out at a temperature of 30°C. The external saline solution contained (in IIIM): 146 NaCI, 5.4 KCl, 1.8 CaCI,, 0.8 MgSO,, 0.4 KH,PO,, 0.3 Na,HPO,, 5 glucose, and 20 HEPES, A 8-br-cGMP plus 10 PM curare and 1 PM tetrodotoxin ('ITX), pH 7.4. The Nat-free, high-CaZf saline contained (in ITIM): 90 Tris-HCI, 5.4 KCl, 25 CaCI,, 0.8 MgSO,, 10 tetraethylammonium (TEA) chloride, 5 glucose, and 25 HEPES, plus 10 PM o-tubocurarine and 1 PM 'ITX. The bath volume (500 ~1) was exchanged with a gravity perfusion system (half-time for exchange -2 set). Carbachol was dissolved in saline and applied at a final concentration of 1 mM (EC,,, for Ca*+ release = 100 pM) (Wang and Thompson, 1994) . No-monomethyl-L-arginine (L-NMMA), NC-monomethyl-D-arginine (D-NMMA), and 6-anilinoquinoline-5,8-quinone (LY83583) were from Calbiochem (La Jolla, CA). Rp-8-pCPT-cGMPS was from BioLog (La Jolla, CA). All other chemicals were from Sigma (St. Louis, MO). LY83583 was dissolved in DMSO and diluted to the appropriate concentration on the day of the experiment.
Nystutin-patch clump. The nystatin perforated-patch technique was used for whole-cell voltage clamp (Horn and Marty, 1988 Calibration of fluorescence to units of Ca*+ was performed off-line using a pipeline image processor (Megavision, Santa Barbara, CA).
Background-subtracted and frame-averaged F34~,/F3x,~ ratios were calibrated using standard solutions between two coverslips, according to the assuming finite permeability of nystatin to Cl-and adequate time for equations of Grynkiewicz et al. (1985) . Intracellular Ca*+ concentrations were measured in regions of interest corresponding to the interiors of individual cell bodies. Calcium kinetics were resolved by monitoring cells equilibration.
Nystatin was added to filtered pipette solution from a continuously for up to 2 min with 380 nm excitation after first obtaining DMSO stock (2.5 mg nystatin in 50 ~"1 DMSO) to a final concentration of Fi4cJF380. Because dye fade during this period was insignificant, only an initial ratiometric determination was needed at the beginning of each 100-200 kg/ml, and this solution was used within the hour. Patch elecrecord. The mltlal F3so and [Cal, in individual cells allowed the calculatrodes were made from Borofilament glass (Sutter Instrument, Novato, tion of F,,, and F,,,,,, CA). Membrane currents were recorded using a List EPC-7 amplifier and corresponding to zero and saturating Ca*+ concentrations, using the equations:
PClamp software. Series resistance ranged from 20 to 40 mR, and -50% compensation was used, allowing the cell capacitance to be compensated adequately. A holding voltage of -60 mV was used, which is near the normal resting potential.
Cu' ' imaging. Cells were loaded with the Ca* ' indicator Fura-by 17 min, the chamber was rinsed again with the same saline plus 2 mM 8-bromo-cGMP (1 mM) in a cell bathed in Na'-free, high-Ca*' saline and voltage-clamped to -60 mV. At the time indicated by the bar, the chamber was rinsed with Nat -free saline plus 1 mM S-bromo-cGMP. After \, .
saline. The procedure was repeated 3 min later ising 2 mM Ba'~' (Bu) in place of Mn*' Interruptions in the record correspond to times when voltage-clamp pulses were applied to measure the I-V curve.
gradual entry of the cyclic nucleotide into the cell and is consistent with an intracellular site of action. The cyclic nucleotide also activates inward current in cells bathed in Na+-free, high-Ca2+ saline containing 25 mM Ca 2-t, indicating that substantial current can be carried by Ca2+ (Fig. lI? ) (current density = 0.63 pA/pF after 15 min). The inward current is reversibly blocked by 2 mM external Mn2+ or 2 mM Ba2+, whether the cells are bathed in normal saline or in Na+-free, high-Ca2+ saline (Fig. 1B) .
The difference current-voltage (Z-11 curve for the cyclic nucleotide-dependent current in high-Ca2+ saline is shown in Figure 2 . The points were obtained by subtracting control currents measured during pulses to voltages between -95 and -50 mV from currents measured during the same pulse series 15 min after adding 1 mM 8-bromo-cGMP. Difference currents calculated in this way changed instantaneously during voltage steps without evidence of time-dependent gating, indicating that the activation process is not voltage dependent within this range. The positive slope of the I-V curve shows that the cyclic nucleotide causes a conductance increase, but it was not possible to extend the curve to voltages more positive than -50 mV or to measure a reversal potential, because other strongly voltage-dependent Ca2+ currents begin to activate with larger steps (Yoshii et al., 1988) . Because the cGMP-dependent current is expected to be a minor component of the total Ca2+ current at depolarized voltages, it was not practical to use a pharmacological approach to isolate it. The dashed line in Figure 2 is the expected Z-V curve for a Ca2+ current calculated from the Goldman-Hodgkin-Katz current equation, with extracellular calcium ([Cal,) equal to 25 mM and [Cal, at later times could then be calculated from F7s,, using the Henderson-Hasselbalch equation, as is done for single-wavelength dyes (Kao et al., 1989) . Figure L4 . When 1 mM S-bromocGMP was introduced in normal external saline with 1 WM TTX, an inward current gradually developed that reached a current density of 0.41 pA/pF after 15 min at the -60 mV holding potential. The slow onset of the current probably results from mV -100
Figure 2. Difference I-V curve in high-Ca*+ saline. A series of 300 msec pulses to voltages between -95 and -50 mV was applied from a holding voltage of -60 mV before and 15 min after applying 1 mM S-bromocGMP. The experiment was carried out in Nat-free, high-Ca2+ saline containing 10 IIIM TEA and 1 pM TTX. Data points were obtained by subtracting the steady-state current measured during each step in normal saline from the current during the corresponding step in cGMP. The dashed line shows the expected 1-P' curve for a Ca2+ current calculated from the Goldman-Hodgkin-Katz current equation assuming [Cal, = 70 nM and [Cal, = 25 mfvt. [Cal, equal to 70 IIM. This provides a reasonable approximation to the data and suggests a reversal potential more positive than +40 mV. Because the Z-V curve was measured in Nat-free external saline, Nat is excluded as the carrier of inward current. Contamination from potassium currents is minimal because the pipette solution contained 156 mM Cs+ in place of K+, and the external saline contained 10 mM TEA to suppress currents flowing in potassium channels. In addition, the calculated equilibrium potential for Cll is -60 mV, equivalent to the holding potential. Under these conditions, Ca2+ 1s the most likely candidate to carry the cyclic nucleotide-dependent inward current. For these reasons, and because the current is blocked by Mn2+ and Ba2+, we conclude that Ca2+ carries a significant fraction of the current activated by %bromo-cGMP, even in normal saline.
The amplitudes of cyclic nucleotide-dependent inward currents measured in normal saline (average current density = 0.40 ? 0.12 pA/pF, mean ? SEM; IZ = 8) and high-Ca2+ saline (0.27 ? 0.18 pA/pF; IZ = 3) were not statistically different (p = 0.6, two-tailed t test). This does not match the simple expectation for a Ca2+-selective current because one would expect the current density at a particular voltage to increase as the external Ca2+ concentration is raised. One possible explanation is that the current may saturate at Ca2+ concentrations above the physiological level in a manner similar to what is seen with voltage-dependent Ca2+ channels (Almers and McCleskey, 1984; Hess and Tsien, 1984) . Alternatively, the pathway may be permeable to both Na+ and Ca2+ with a conductance that depends on the ratio of permeant ion concentrations (Hagiwara, 1983; Hess and Tsien, 1984) . The present data are not sufficient to decide between these alternatives.
8-Bromo-cGMP increases Ca*+ influx Fura-fluorescence imaging was used to measure changes in intracellular Ca2+ concentration during the application of K-bromo-cGMP. Figure 3A shows an example from a single cell bathed in normal saline; the result is representative of 20 experiments. Calcium concentration was measured ratiometrically at successive time points before and after adding 1 mM %bromo-cGMP to the bath. The figure voltage clamp, which supports the conclusion that the inward current activated by 8-bromo-cGMP is carried in part by Ca2+. This effect was specific for cGMP because bath application of 1 mM S-bromo-CAMP under the same conditions did not change [Cal, in any of the 10 experiments (Fig. 3B) . The increase in intracellular Ca2+ concentration results from increased Ca2+ influx. In the example in Figure 3C , the cell was exposed first to normal saline containing 1 mM S-bromo-cGMP. After 20 min, the external saline was exchanged for one containing the same concentration of cyclic nucleotide but a much lower Ca*+ concentration (1.8 mM Ca2+ plus 4 mM EGTA; 70 nM free Ca2+), which resulted in a decrease in [Cal, toward the resting level. This was reversed when normal saline was reintroduced. This result is representative of experiments on 20 cells and shows that the [Cal, increase caused by 8-bromo-cGMP is the result of Ca2+ influx from the extracellular compartment rather than Ca2+ release from intracellular stores.
The NO generator sodium nitroprusside (SNP) stimulates cGMP production in NlE-115 cells (McKinney et al., 1990; Thompson et al., 1995) . We found that 100 PM SNP, dissolved in normal saline, also causes the intracellular Ca2+ concentration to increase rapidly, reaching a value of 47 -t 16 nM (mean -C SEM; . The initial holding current is shown by the &shed line; 1 mM carbachol (CCh) was applied for 1 min at the time indicated by the bur. The inward current amplitude was 83 pA. B, The agonist was rinsed away, and 1 mM 8-bromocGMP was added to the external saline. The cyclic nucleotide activated an inward current of 56 pA. After 15 min, carbachol (CC/r) was applied a second time and caused an increment in inward current of 21 pA. C, Fura-imaging shows that incubation with S-bromo-cGMP reduces the late phase of the Ca*+ response to carbachol (CC/z). Cells loaded with Fura-2/AM were stimulated twice with 1 IIIM carbachol (exposure to carbachol indicated by the bar). During the first stimulation, the cells were bathed in normal external saline. The solid line shows the average Ca*+ response (n = 10). After rinsing, the saline was exchanged for one containing 1 mM 8-bromo-cGMP. After 15 min, 1 ITIM carbachol was applied a second time. The Ca*+ response (dashed line) was corrected for the change in basal [Cal, level and normalized to the peak of the control response. II = 9) above the resting level within 90 sec. Incubation with 100 PM SNP for periods as long as 5 min had no effect on the peak amplitude of the Ca2+ response to carbachol. Because the peak [Cal, change reflects intracellular Ca2+ release rather than Ca2+ influx (Mathes and Thompson, 1994) , this finding shows that SNP does not alter the Ca2+ content of the IP,-releasable Ca2+ pool or the ability of agonist to stimulate Ca2+ release. These experiments provide further evidence that stimulation of the NO/guanylyl cyclase pathway is sufficient to activate Ca2+ influx.
cGMP and muscarinic agonist activate the same inward current The inward current activated by S-bromo-cGMP has several properties in common with the voltage-independent inward current activated by muscarinic agonist. In both cases the current is carried in part by Ca2+, and the currents reach approximately the same maximum current density. Both currents are susceptible to block by external Mnzt and Ba2+, a property that is distinctly different from the other highly voltage-dependent Ca2+ channels expressed in these cells (Mathes and Thompson, 1994) . These observations suggest that cGMP and muscarinic agonists might activate the same pathway. If this were so, we would expect that The responses were normalized to the same peak amplitude.
cGMP would compete with carbachol for activation of the current and thereby reduce the increment in current amplitude that occurs when carbachol is applied. Figure 4 shows the results of a voltage-clamp experiment designed to test this prediction. In A, the current in response to 1 mM carbachol reached a steady amplitude of 83 pA. The agonist was washed away, and the cell was incubated in saline containing 1 mM 8-bromo-cGMP. This resulted in an inward current that reached 56 pA after 15 min. Carbachol was applied a second time in the presence of 8-bromocGMP, and now the agonist activated an inward current of 21 pA, 25% of the control current amplitude. The decrease in the carbachol response is in approximate proportion to the inward current activated by 8-bromo-cGMP. In three experiments, the average decrease in the carbachol response after 15 min in 1 mM 8-bromo-cGMP was 91 ? 11% (mean ? SD). The observation that the inward currents activated by 8-bromocGMP and by carbachol do not sum is consistent with the hypothesis that cGMP and agonist activate the same pathway. This was tested further in a Fura-imaging experiment. The Ca2+ response to 1 mM carbachol was recorded in the same group of 10 cells, first under control conditions and then after a 15 min incubation with 1 mM 8-bromo-cGMP. The cyclic nucleotide caused a 50-100 nM increase in [Cal, in different cells. The average peak amplitude of the response to the second carbachol application was 8% smaller than the first response, which is approximately the decrease ex- petted from muscarinic receptor desensitization under control conditions (Wang and Thompson, 1994; Mathes and Thompson, 1995) . We showed previously that the peak increase in [Cal, is attributable to Ca2+ release from internal stores and that Ca2+ influx does not contribute to the signal until after the peak (Mathes and Thompson, 1994) . The observation that the peak [Cal, increase does not change more than expected from desensitization makes two points. It shows that 8-bromo-cGMP does not inactivate the agonist receptor or the intermediate steps in the signaling cascade that lead to intracellular Cazt release. It also shows that the cyclic nucleotide does not by itself deplete intracellular stores of Ca'+. This is important because store depletion could cause the production of an independent factor, unrelated to cGMP, that could act as a second messenger to activate a refilling Ca2+ current (Putney and Bird, 1993) . Figure 4C shows the average calcium signal during the application of carbachol under control conditions (solid line) and after S-bromo-cGMP (dashed line). The change in basal [Cal, was subtracted and the responses were normalized to the same peak amplitude to emphasize the change in waveform. The Ca2+ signal decays more rapidly in cells treated with cGMP than in control cells. Calcium influx normally contributes to the Ca2+ signal at this late stage, prolonging the falling phase of the response (Mathes and Thompson, 1994) . Because the response waveform does not change during repeated applications of agonist under control conditions, the increased rate of decay of [Cal, is a result of the exposure to cyclic nucleotide (Wang and Thompson, 1994) . Our interpretation is that incubation with S-bromo-cGMP activates Ca2+ influx toward saturation and thereby reduces the further activation of Ca2+ influx by agonist. The decrease in the late phase of the [Cal, response to agonist by previous exposure to S-bromo-cGMP supports the hypothesis that cGMP and carbachol activate the same Ca2+ influx pathway.
The activation of Ca2+ influx by muscarinic agonist is prevented by inhibitors of NO-synthase In this cell line, activation of Ml receptors by carbachol causes a rapid increase in cGMP. cGMP production is prevented when F@re 6. L-NMMA does not prevent the activation of inward current by Sbromo-cGMP.
A, Nystatin-patch recording of membrane current activated by 1 mM carbachol (CC/z) ( g a onist application indicated by bar; normal saline; -60 mV holding potential). B, The agonist was washed from the chamber, and saline containing 100 pM L-NMMA was added. After 15 min, 1 IIIM carbachol (CC/z) was applied a second time and failed to elicit a response. C, The agonist was rinsed from the chamber, again with saline containing 100 pM L-NMMA, and 1.5 min later saline containing 1 IIIM Sbromo-cGMP plus 100 FM L-NMMA was added. The records were extracted from a continuous recording from the same neuron.
NO-synthase is blocked with the competitive inhibitor L-NMMA (McKinney et al., 1990; Thompson et al., 1995) , and in the present experiments we found that L-NMMA also prevents the activation of Ca2+ influx by carbachol. An example is shown in Figure 5 . Application of 1 mM carbachol under control conditions activated an inward current that reached an amplitude of 43 pA (Fig. 54) . The cell was incubated in saline containing 100 FM L-NMMA for 15 min before carbachol was applied a second time. On the second application, the agonist elicited an inward current of 5 pA, equal to 11% of the control value (Fig. 5B ). In four experiments with 100 PM L-NMMA, the inhibitor reduced the inward current by 96 2 9% (mean -t SD) ( Table 1) . Identical treatment with the inactive isomer D-NMMA had no effect on the activation of inward current by carbachol (Table 1) . 8-Bromo-cGMP is able to activate inward current in the presence of L-NMMA.
In the example illustrated in Figure 6 , carbachol activated an inward current of 106 pA under control conditions (A). After a 15 min incubation with 100 PM L-NMMA, a second application of carbachol failed to activate inward current, indicating that the pathway was completely blocked (B). The agonist was rinsed from the chamber, and 1 mM 8-bromo-cGMP was added in the continued presence of L-NMMA.
This resulted in a gradual increase in inward current that reached 35 pA after 15 min (C), indicating that the cyclic nucleotide can bypass the NO pathway to activate the current directly.
Fura-imaging experiments showed that inhibition of NOsynthase with L-NMMA reduces Ca2+ influx in response to muscarinic agonist. Figure 5C shows the average change in [Cal, in 10 A B mV; 1 mM carbachol (CCh) dissolved in saline plus 10 pM LY83583 was applied at the time indicated by the bar. B, The agonist and LY83583 were washed from the chamber with normal saline, and after 15 min 1 mM carbachol (CC/z) was applied a second time. C, Fura-imaging shows that LY83583 reduces the plateau in the Ca*+ response to carbachol (CCh). Cells loaded with Fura-were incubated with saline containing 10 FM LY83583 for 15 min before stimulating with 1 IIIM carbachol dissolved in the same saline. The average Ca'+ response is shown by the solid line (n = 10; carbachol stimulation indicated by the bar). The inhibitor was rinsed from the chamber with normal saline. After 15 min, 1 mM carbachol was applied a second time, and the average response in the same 10 cells is shown by the dashed line (normalized by peak amphtude).
cells during carbachol stimulation under control conditions (solid line). The falling phase of the Cazt signal is characterized by a plateau that results from Cazt influx (Mathes and Thompson, 1994) . After the agonist was washed away, the cells were incubated with 100 FM L-NMMA for 15 min before carbachol was applied a second time (dashed line; normalized to the peak of the control response). This had no effect on the basal level of [Cal,. The peak amplitude of the Cazt response during the second agonist application was reduced by ll%, a decrease within the range expected from muscarinic receptor desensitization. L-NMMA caused a greater decrease in the plateau, which is consistent with inhibition of Ca2+ influx. D-NMMA had no effect on the Ca2+ response to carbachol. We conclude that the NOsynthase inhibitor prevents the activation of Ca" influx by agonist, but L-NMMA does not cause Ca*+ release by itself and does not affect Ca2+ release by agonist.
Inhibition of guanylyl cyclase blocks activation of Ca2+ current by agonist
The guanylyl cyclase inhibitor LY83583 (Mulsch et al., 1988) blocks the activation of inward current by carbachol. In the example shown in Figure 7A , the cell was incubated in saline containing 10 PM LY83.583 for 15 min before a saturating concentration of carbachol(1 mM) was applied in the continued presence of inhibitor. There was no effect of agonist on mem- brane current under these conditions. The chamber was rinsed with normal saline, and 15 min later the agonist was applied a second time. Carbachol now activated an inward current that reached 100 pA (Fig. 7B ). In three cells tested in this way, LY83583 completely and reversibly blocked the activation of inward current by agonist (Table 1) . By using Fura-imaging, we found that LY83583 reduces the plateau in the Cazt response, which is the expected result if Cazt influx is blocked. Figure 7C shows the increase in [Cal, during stimulation with 1 mM carbachol measured after a 15 min incubation with 10 PM LY83583 (solid line) and again 15 min after washing the inhibitor from the chamber (dashed line; normalized by peak amplitude). The inhibitor had no effect on basal Ca2+ concentration or on the peak amplitude of the Ca2+ response, but it strongly reduced the plateau. This provides pharmacological evidence that the activation of inward current by muscarinic agonist requires guanylyl cyclase activity.
Rp-8-pCPT-cGMPS prevents activation of Ca*+ influx by agonist
The membrane-permeable cGMP analog Rp-&pCPT-cGMPS competes with cGMP for binding sites on cGMP-dependent protein kinase and acts as a competitive inhibitor of that enzyme (Butt et al., 1994) . It may act in a similar way at cGMP binding sites associated with ion channels (Kramer and Tibbs, in press ), although it apparently does not affect cGMP-regulated phosphodiesterases (Butt et al., 1994) . In the example shown in Figure  &I , the inward current in response to 1 mM carbachol was re-corded first under control conditions and reached an amplitude of 167 pA. After 15 min in 10 pM Rp-&pCPT-cGMPS, carbachol was applied again, and the current reached 50 pA, 30% of the control response (Fig. SB) . In five cells, 10 PM Rp-S-pCPT-cGMPS reduced the inward current by 73 + 27% (mean t SD; Table 1 ). Because the inhibitory cGMP analog competes with cGMP for binding sites on effector molecules, the strength of block is expected to increase with inhibitor concentration. In agreement with this prediction, we found that 15 min exposure to 100 PM Rp-SpCPT-cGMPS prevented the activation of inward current by agonist. These data support the view that cGMP binding is necessary for activation of the current. This is supported by Fura-imaging experiments. Figure SC shows the change in [Cal, during the application of 1 mM carbachol under control conditions (solid line) and after a 15 min exposure to 100 pM Rp-8-pCPT-cGMPS.
The result is representative of 10 experiments. The inhibitor had no effect on the resting Cazf concentration or on the peak change in [Cal,, which shows that it did not alter the Cazt content of internal stores or the ability of agonist to mobilize Ca'+. Rp-8-pCPT-cGMPS did reduce the plateau phase of the response, which is consistent with decreased Ca2+ influx.
DISCUSSION
On the basis of these experiments, we conclude that cGMP is the necessary and sufficient link between muscarinic receptor activation and the activation of voltage-independent Ca2+ current. The same conclusion was reached for the activation Ca2+ influx in pancreatic acinar cells (Pandol and Schoeffield-Payne, 1990; Bahnson et al., 1993; Xu et al., 1994) and in an epithelial cell line (Bischof et al., 1995) . Like the situation in acinar cells, the Ca2+ current in NlE-115 neuroblastoma cells is activated specifically by cGMP, and CAMP does not share this activity.
Evidence that 8-bromo-cGMP activates Ca2+ influx includes the following observations. The inward current is seen when cells are bathed in Nat-free saline when Ca2' is present, and in this solution the extrapolated reversal potential is consistent with a Ca2+ current. The cyclic nucleotide also elevates [Cal, in Fura-imaging experiments, and this develops over the same time course as the inward current measured with voltage clamp. The [Cal, increase results exclusively from Ca2+ influx rather than from Ca2+ release from internal stores. The inward current activated by 8-bromo-cGMP is blocked by external Mn2+ and Ba'+, and this unusual ionic sensitivity is shared with the inward current activated by muscarinic agonist (Mathes and Thompson, 1994) . In addition, the currents activated by S-bromo-cGMP and by muscarinic agonist are are not additive, indicating that agonist and S-bromo-cGMP activate the same membrane current.
Muscarinic receptor activation causes a pronounced, 16-fold increase in cGMP within 30 set . This is blocked by L-NMMA, a competitive inhibitor of NO-synthase, demonstrating that all of the guanylyl cyclase activity is attributable to the NO-sensitive form of the enzyme rather than to receptor-coupled cyclases (McKinney et al., 1990; Hu and ElFakahany, 1993; Thompson et al., 1995) . The activation of inward current by agonist is also blocked by L-NMMA without affecting IP, production (McKinney et al., 1990; Thompson et al., 1995) . In addition, LY83583, a reversible inhibitor of guanylyl cyclase, and the cyclic nucleotide analog Rp-8-pCPT-cGMPS, a competitive inhibitor of cGMP-dependent protein kinase as well as cyclic nucleotide-gated channels (Butt et al., 1994; Kramer and Tibbs, in press ), prevents the activation of inward current and Ca2+ influx Figure 9 . Model for the activation of Ca*+ current by muscarinic agonist. Binding of agonist to Ml receptors (ml) activates phospholipase-C (PLC) via a G-protein (G). The resulting increase in IP.T concentration activates receptors associated with intracellular Ca2+ storage compartments to release Ca*+ into the cytosol. Ca2+ bound to calmodulin then activates NO-synthase (NOS), which catalyzes conversion of L-arginine to NO and citrulline. NO activates soluble guanylyl cyclase (GC) to produce cGMP. cGMP activates Cu'+ influx either by acting directly on cyclic nucleotidegated ion channels or via an additional intermediate, for example, cGMPdependent protein kinase (PKG; dashed line).
by agonist. None of the inhibitors affect Ca2~+ release from internal stores or the Ca2+ content of stores, which shows that inhibition of cGMP production uncouples Ca2+-store depletion from the activation of Ca2+ current.
Stimulation of NO-synthase requires Ca2'/calmodulin, and cGMP production is prevented when the Ca2+ buffer bis(2-aminophenoxy)ethane-jV,N,N',N'-tetra-acetic acid (or BAPTA) is introduced into the cell . During the muscarinic response, NO-synthase is driven in part by Ca2+ released from IP,-sensitive intracellular Ca2+ stores , and therefore the cGMP signal has the potential to encode the depletion of Ca2+ stores. Maximum stimulation of cGMP production by carbachol, however, requires Ca2+ influx in addition to Ca2+ release. We found that cGMP production is reduced by 60% when Ca2+ influx is prevented under conditions in which Ca2+ release is not altered. This was interpreted as evidence that NO-synthase, or a necessary cofactor such as calmodulin, is localized to the vicinity of membrane Ca2+ channels (Thompson et al., 3995) . Because cGMP formation is strongly dependent on Ca2+ influx and because Ca2+ influx is activated by cGMP, this pathway represents a positivefeedback loop that is critically poised to amplify the NO and cGMP signals. The feedback loop is diagrammed in Figure 9 . This amplification process may explain the very rapid increase in cGMP concentration that occurs during the activation of muscarinic receptors.
The mechanism by which cGMP activates Ca2+ current in NlE-115 cells is not known, but there are two reasonable possibilities. cGMP might directly activate a cyclic nucleotide-gated channel, or it might act indirectly, through a cGMP-dependent kinase or phosphatase for example, to modulate Ca2+ channels. Cyclic nucleotide-gated channels have been described in photoreceptors, olfactory neurons, and nonsensory neurons of vertebrates (Distler et al., 1994) and invertebrates (Huang and Gillette, 1993) . Members of this family of heteromultimeric proteins share sequence homology in the cGMP-binding domain, but there is wide variability outside of this region, including variability in membrane-spanning segments thought to constitute the ion pore. This suggests that different members of the family may have different patterns of ionic selectivity or sensitivity to regulatory ligands. The inward currents activated by Sbromo-cGMP and muscarinic agonist in NlE-115 neuroblastoma cells share several properties with cyclic nucleotide-gated channels, including the absence of voltage dependence, a conductance to Ca2+ that seems to saturate readily with increasing concentration (Hodgkin et al., 1985) possible Ca2+-dependent inactivation or self-block (Liu et al., 1994) and lack of permeability to Ba2+ and Mn2+ when Ca2+ is present (Capovilla et al., 1983) . A definitive test for the presence of cyclic nucleotide-gated channels in NlE-11.5 cells will require additional experiments.
